Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 12.15 1.17% 0.14
PTCT closed up 1.17 percent on Friday, April 28, 2017, on 35 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: May 8

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PTCT trend table...

Date Alert Name Type % Chg
Apr 27 NR7 Range Contraction 1.17%
Apr 27 Narrow Range Bar Range Contraction 1.17%
Apr 25 NR7 Range Contraction 2.62%
Apr 25 NR7-2 Range Contraction 2.62%
Apr 24 NR7 Range Contraction 4.92%
Apr 24 NR7-2 Range Contraction 4.92%
Apr 21 NR7 Range Contraction 6.86%
Apr 21 New Uptrend Bullish 6.86%
Apr 20 50 DMA Support Bullish 8.00%
Apr 20 Upper Bollinger Band Walk Other 8.00%

Older signals for PTCT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Is PTCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 16.5
52 Week Low 4.03
Average Volume 1,428,733
200-Day Moving Average 10.3968
50-Day Moving Average 10.7372
20-Day Moving Average 10.772
10-Day Moving Average 11.53
Average True Range 0.5607
ADX 34.2
+DI 30.53
-DI: 7.89
Chandelier Exit (Long, 3 ATRs) 10.6679
Chandelier Exit (Short, 3 ATRs) 10.3021
Upper Bollinger Band 12.484
Lower Bollinger Band 9.06
Percent B (%b) 0.9
Bandwidth 0.317861